Current Radiopharmaceuticals
Volume 12, 3 Issues, 2019
ISSN: 1874-4729 (Online)
ISSN: 1874-4710 (Print)
This journal supports open access
ISSN: 1874-4729 (Online)
ISSN: 1874-4710 (Print)
This journal supports open access
Aims & Scope
Current Radiopharmaceuticals publishes original research articles, letters, full-length/mini reviews, drug clinical trial studies and guest edited issues on all aspects of research and development of radiolabelled compound preparations, covering studies related to nuclear medicine, molecular imaging, radionuclide therapy, as radiology, oncology and radiotherapy and basic research. The scope of the journal also covers the following areas: radio imaging techniques, therapies; preparation and application of radionuclide compounds including the incorporation of tracer methods used in scientific research and applications.
Current Radiopharmaceuticals
,Volume 12
-Number 2
Editorial Open Access
Molecular Imaging and Theranostics in Pancreatic Neuroendocrine Tumours: From a Luminous Present to an Even Brighter Future
, 12(2): 93 - 95Mapelli Paola and Luigi Mansi
DOI: 10.2174/187447101202190530074002
Molecular Imaging and Theranostics in Pancreatic Neuroendocrine Tumours: From a Luminous Present to an Even Brighter Future
Perspective Open Access
PET/MRI in Neuroendocrine Tumours: Blessings and Curses
, 12(2): 96 - 97Mapelli Paola, De Cobelli F and Maria Picchio
DOI: 10.2174/1874471012999190404151701
PET/MRI in Neuroendocrine Tumours: Blessings and Curses
Review Article
Physiopathological Premises to Nuclear Medicine Imaging of Pancreatic Neuroendocrine Tumours
, 12(2): 98 - 106Vincenzo Cuccurullo*, Giuseppe Danilo Di Stasio and Luigi Mansi
DOI: 10.2174/1874471012666190206094555
Physiopathological Premises to Nuclear Medicine Imaging of Pancreatic Neuroendocrine Tumours
Review Article Open Access
State of the Art and Recent Developments of Radiopharmaceuticals for Pancreatic Neuroendocrine Tumors Imaging
, 12(2): 107 - 125Angela Carollo*, Stefano Papi, Chiara M. Grana, Luigi Mansi and Marco Chinol
DOI: 10.2174/1874471012666190306104450
State of the Art and Recent Developments of Radiopharmaceuticals for Pancreatic Neuroendocrine Tumors Imaging
Review Article
Peptide Receptor Radionuclide Therapy for Pancreatic Neuroendocrine Tumours
, 12(2): 126 - 134Shahad Alsadik, Siraj Yusuf and Adil AL-Nahhas*
DOI: 10.2174/1874471012666190201164132
Peptide Receptor Radionuclide Therapy for Pancreatic Neuroendocrine Tumours
Review Article
Imaging of Pancreatic-Neuroendocrine Tumours: An Outline of Conventional Radiological Techniques
, 12(2): 135 - 155Muhammad Affan Zamir, Wasim Hakim*, Siraj Yusuf and Robert Thomas
DOI: 10.2174/1874471012666190214165845
Imaging of Pancreatic-Neuroendocrine Tumours: An Outline of Conventional Radiological Techniques
Review Article
Gamma Emitters in Pancreatic Endocrine Tumors Imaging in the PET Era: Is there a Clinical Space for 99mTc-peptides?
, 12(2): 156 - 170Vittorio Briganti*, Vincenzo Cuccurullo, Giuseppe Danilo Di Stasio and Luigi Mansi
DOI: 10.2174/1874471012666190301122524
Gamma Emitters in Pancreatic Endocrine Tumors Imaging in the PET Era: Is there a Clinical Space for 99mTc-peptides?
Articles Ahead of Print
Toward the Discovery and Development of PSMA Targeted Inhibitors for Nuclear Medicine Applications
Sara Pastorino, Mattia Riondato, Licia Uccelli, Giampiero Giovacchini, Elisabetta Giovannini, Valerio Duce and Andrea Ciarmiello*
DOI: 10.2174/1874471012666190729151540
View Abstract View on PubMed
The Screening of Renoprotective Agents by 99mTc-DMSA: A Review of Preclinical Studies
Masoud Rezaei , Maryam Papie, Mohsen Cheki*, Luigi Mansi, Sean Kitson and Amirhossein Ahmadi
DOI: 10.2174/1874471012666190717142316
View Abstract
Comparison of 99mTc Injected Activity with Prescribed Activity in Four Types of Nuclear Medicine Exams
Muhammad Isa Khan, Umme Farwa, Tahir Iqbal, Saadat Ali, Aalia Nazir and Mohsin Ijaz*
DOI: 10.2174/1874471012666190620144803
View Abstract View on PubMed
Comparison Between 18F-Dopa and 18F-Fet PET/CT in Patients with Suspicious Recurrent High Grade Glioma: A Literature Review and Our Experience
Laura Evangelista*, Lea Cuppari, Luisa Bellu, Daniele Bertin, Mario Caccese , Pasquale Reccia, Vittorina Zagonel and Giuseppe Lombardi
DOI: 10.2174/1874471012666190115124536
View Abstract View on PubMed
68Ga/64Cu PSMA Bio-Distribution in Prostate Cancer Patients: Potential Pitfalls for Different Tracers
Ferdinando Calabria*, Robert Pichler, Mario Leporace, Johannes Wolfsgruber, Pierluigi Coscarelli, Andreas Dunzinger, Orazio Schillaci, Giuseppe Lucio Cascini and Antonio Bagnato
DOI: 10.2174/1874471012666190515090755
View Abstract View on PubMed
Pre-feasibility Study for Establishing Radioisotope and Radiopharmaceutical Production Facilities in Developing Countries
Efrain Araujo Perini *, Mikhail Skopchenko, Tran Thu Hong , Rahmat Harianto , Alexis Maître, Maidelys Rosa Rodríguez Rodríguez , Nathalia de Oliveira Santos , Yinglei Guo, Xiangyu Qin , Carlos A. Zeituni and Valeriia N. Starovoitova
DOI: 10.2174/1874471012666190328164253
View Abstract View on PubMed
Evaluation of the Radioprotective Effects of Melatonin Against Ionizing Radiation-Induced Muscle Tissue Injury
Dheyauldeen Shabeeb, Mansoor Keshavarz , Alireza Shirazi*, Gholamreza Hassanzadeh*, Mohammed Reza Hadian, Azin Nowrouzi, Masoud Najafi* and Ahmed Eleojo Musa
DOI: 10.2174/1874471012666190219120329
View Abstract View on PubMed
New 99mTc Radiotracers for Myocardial Perfusion Imaging by SPECT
Wei Fang* and Shuang Liu*
DOI: 10.2174/1874471012666190206102214
View Abstract View on PubMed
O-(2-[18F]-Fluoroethyl)-L-Tyrosine (FET) in Neurooncology: A Review of Experimental Results
Carina Stegmayr*, Antje Willuweit, Philipp Lohmann and Karl-Josef Langen
DOI: 10.2174/1874471012666190111111046
View Abstract View on PubMed
Feasibility and Evaluation of Automated Methods for Radiolabeling of Radiopharmaceutical Kits with Gallium-68
Alban Revy, François Hallouard*, Sandrine Joyeux-Klamber, Andrea Skanjeti, Catherine Rioufol and Marc Fraysse
DOI: 10.2174/1874471012666190110170623
View Abstract View on PubMed
Abstracts Ahead of Print
Preparation and biological evaluation of 67Gallium- labeled Iranian Hemiscorpius lepturus scorpion venom
Amir Jalali*, Mona Haddad Zahmatkesh, Amir Reza Jalilian, Amir Taheri Borujeni and Behrouz Alirezapour
DOI: 10.2174/1874471012666190828155227
View Abstract
Published Contents
- Current Radiopharmaceuticals, Volume 12, 2019
- Current Radiopharmaceuticals, Volume 11, 2018
- Current Radiopharmaceuticals, Volume 10, 2017
- Current Radiopharmaceuticals, Volume 9, 2016
- Current Radiopharmaceuticals, Volume 8, 2015
- Current Radiopharmaceuticals, Volume 7, 2014
- Current Radiopharmaceuticals, Volume 6, 2013
- Current Radiopharmaceuticals, Volume 5, 2012
- Current Radiopharmaceuticals, Volume 4, 2011
- Current Radiopharmaceuticals, Volume 3, 2010
- Current Radiopharmaceuticals, Volume 2, 2009
- Current Radiopharmaceuticals, Volume 1, 2008
Editor's Choice
Physiopathological Premises to Nuclear Medicine Imaging of Pancreatic Neuroendocrine Tumours
, 2019; 12(2): 98 - 106Vincenzo Cuccurullo*, Giuseppe Danilo Di Stasio and Luigi Mansi
DOI: 10.2174/1874471012666190206094555
[18F]Amylovis as a Potential PET Probe for β-Amyloid Plaque: Synthesis, In Silico, In vitro and In vivo Evaluations
, 2019; 12(1): 58 - 71Suchitil Rivera-Marrero, Laura Fernández-Maza, Samila León-Chaviano, Marquiza Sablón-Carrazana, Alberto Bencomo-Martínez, Alejandro Perera-Pintado, Anais Prats-Capote, Florencia Zoppolo, Ingrid Kreimerman, Tania Pardo, Laura Reyes, Marcin Balcerzyk, Geyla Dubed-Bandomo, Daymara Mercerón-Martínez, Luis A. Espinosa-Rodríguez, Henry Engler, Eduardo Savio* and Chryslaine Rodríguez-Tanty*
DOI: 10.2174/1874471012666190102165053
The Production of Ac-225
, 2018; 11(3): 173 - 179Jonathan W. Engle*
DOI: 10.2174/1874471011666180418141357
NorthStar Perspectives for Actinium-225 Production at Commercial Scale
, 2018; 11(3): 180 - 191James T. Harvey*
DOI: 10.2174/1874471011666180515123848
Ga-68 Nanoparticles and Ultra-small Nanoparticle: Next Generation of PET Radiopharmaceuticals?
, 2018; 11(2): 123 - 129Mohammed Al-Qahtani, Yousif Al Malki, Hadeel Mutwali, Edward Helal-Neto and Ralph Santos-Oliveira*
DOI: 10.2174/1874471011666180418110206
Mechanisms of Radiation Bystander and Non-Targeted Effects: Implications to Radiation Carcinogenesis and Radiotherapy
, 2018; 11(1): 34 - 45Rasoul Yahyapour, Elahe Motevaseli, Abolhasan Rezaeyan, Hamid Abdollahi, Bagher Farhood, Mohsen Cheki, Masoud Najafi* and Vilmar Villa
DOI: 10.2174/1874471011666171229123130
Personalized & Precision Medicine in Cancer: A Theranostic Approach
, 2017; 10(3): 166 - 170Partha Choudhury* and Manoj Gupta
DOI: 10.2174/1874471010666170728094008
PET/MR Tomographs: A Review with Technical, Radiochemical and Clinical Perspectives
, 2017; 10(3): 184 - 194Giampiero Giovacchini, Elisabetta Giovannini, Mattia Riondato and Andrea Ciarmiello*
DOI: 10.2174/1874471010666170816125051
β -[18F]Fluoro Azomycin Arabinoside (β -[18F]FAZA): Synthesis, Radiofluorination and Preliminary PET Imaging of Murine A431 Tumors
, 2017; 10(2): 93 - 101Piyush Kumar*, Peter Roselt, Gerald Reischl, Carlene Cullinane, Davood Beiki, Walter Ehrlichmann, David Binns, Ebrahim Naimi, Jennifer Yang, Rodney Hicks, Hans-Juergen Machulla and Leonard I. Wiebe
DOI: 10.2174/1874471010666170313120540
Experiences with 99mTc-HMPAO in a Diagnostic Pathway for Violent Patients with Schizophrenic Spectrum Disorders
, 2017; 10(2): 115 - 122Morten Jacobsen*, Arvid Jensen, Guttorm Breivik Storvestre, Tone Marie Bergstrom, Diyar Nori Mohamad Rashi, Bjorn Nielssen , Pal Wiktor and Knut-Erik Hymer
DOI: 10.2174/1874471010666170621122221
Open Access Articles
[18F]Amylovis as a Potential PET Probe for β-Amyloid Plaque: Synthesis, In Silico, In vitro and In vivo Evaluations
, 2019; 12(1): 58 - 71Suchitil Rivera-Marrero, Laura Fernández-Maza, Samila León-Chaviano, Marquiza Sablón-Carrazana, Alberto Bencomo-Martínez, Alejandro Perera-Pintado, Anais Prats-Capote, Florencia Zoppolo, Ingrid Kreimerman, Tania Pardo, Laura Reyes, Marcin Balcerzyk, Geyla Dubed-Bandomo, Daymara Mercerón-Martínez, Luis A. Espinosa-Rodríguez, Henry Engler, Eduardo Savio* and Chryslaine Rodríguez-Tanty*
Dosimetry and Toxicity Studies of the Novel Sulfonamide Derivative of Sulforhodamine 101([18F]SRF101) at a Preclinical Level
, 2019; 12(1): 40 - 48Ingrid Kreimerman, Erick Mora-Ramirez, Laura Reyes, Manuel Bardiès, Eduardo Savio* and Henry Engler
Pre-feasibility Study for Establishing Radioisotope and Radiopharmaceutical Production Facilities in Developing Countries
, 2019; 12: 1 - 14 (E-Pub Ahead of Print)Efrain Araujo Perini *, Mikhail Skopchenko, Tran Thu Hong , Rahmat Harianto , Alexis Maître, Maidelys Rosa Rodríguez Rodríguez , Nathalia de Oliveira Santos , Yinglei Guo, Xiangyu Qin , Carlos A. Zeituni and Valeriia N. Starovoitova
68Ga/64Cu PSMA Bio-Distribution in Prostate Cancer Patients: Potential Pitfalls for Different Tracers
, 2019; 12: 1 - 9 (E-Pub Ahead of Print)Ferdinando Calabria*, Robert Pichler, Mario Leporace, Johannes Wolfsgruber, Pierluigi Coscarelli, Andreas Dunzinger, Orazio Schillaci, Giuseppe Lucio Cascini and Antonio Bagnato
Comparison of 99mTc Injected Activity with Prescribed Activity in Four Types of Nuclear Medicine Exams
, 2019; 12: 1 - 6 (E-Pub Ahead of Print)Muhammad Isa Khan, Umme Farwa, Tahir Iqbal, Saadat Ali, Aalia Nazir and Mohsin Ijaz*
The Screening of Renoprotective Agents by 99mTc-DMSA: A Review of Preclinical Studies
, 2019; 12: 1 - 9 (E-Pub Ahead of Print)Masoud Rezaei , Maryam Papie, Mohsen Cheki*, Luigi Mansi, Sean Kitson and Amirhossein Ahmadi
An Overview of Targeted Alpha Therapy with 225Actinium and 213Bismuth
, 2018; 11(3): 200 - 208Alfred Morgenstern*, Christos Apostolidis, Clemens Kratochwil, Mike Sathekge, Leszek Krolicki and Frank Bruchertseifer
Development of 225Ac Radiopharmaceuticals: TRIUMF Perspectives and Experiences
, 2018; 11(3): 156 - 172Andrew Kyle Henderson Robertson, Caterina Fortunata Ramogida, Paul Schaffer and Valery Radchenko*
Synthesis of [18F]2B-SRF101: A Sulfonamide Derivative of the Fluorescent Dye Sulforhodamine 101
, 2017; 10(3): 212 - 220Ingrid Kreimerman, Williams Porcal, Silvia Olivera, Patricia Oliver, Eduardo Savio* and Henry Engler
Automated One-pot Radiosynthesis of [11C]S-adenosyl Methionine
, 2017; 10(3): 203 - 211Florencia Zoppolo, Williams Porcal, Patricia Oliver, Eduardo Savio* and Henry Engler
Experiences with 99mTc-HMPAO in a Diagnostic Pathway for Violent Patients with Schizophrenic Spectrum Disorders
, 2017; 10(2): 115 - 122Morten Jacobsen*, Arvid Jensen, Guttorm Breivik Storvestre, Tone Marie Bergstrom, Diyar Nori Mohamad Rashi, Bjorn Nielssen , Pal Wiktor and Knut-Erik Hymer
Gallium-68 in Medical Imaging
, 2016; 9(3): 187 - 207Lucia Martiniova, Louis De Palatis, Elba Etchebehere and Gregory Ravizzini
Biodistribution and Dosimetry of 177Lu-tetulomab, a New Radioimmunoconjugate for Treatment of Non-Hodgkin Lymphoma
, 2013; 6(1): 20 - 27Ada H. V. Repetto-Llamazares, Roy H. Larsen, Camilla Mollatt, Michael Lassmann and Jostein Dahle
Targeted α-Particle Therapy: A Clinical Overview
, 2008; 1(3): 251 - 253Massimo Salvatori, Luca Indovina and Luigi Mansi
Radium-223: From Radiochemical Development to Clinical Applications in Targeted Cancer Therapy
, 2008; 1(3): 203 - 208Oyvind S. Bruland, Thora J. Jonasdottir, Darrell R. Fisher and Roy H. Larsen
Most Cited Articles
Review Article
Mechanisms of radiation bystander and non-targeted effects: Implications to radiation carcinogenesis and radiotherapy
, 2018; 11(1): 34-45.Rasoul Yahyapour, Elahe Motevaseli, Abolhasan Rezaeyan, Hamid Abdollahi, Bagher Farhood, Mohsen Cheki, Masoud Najafi* and Vilmar Villa
DOI: 10.2174/1874471011666171229123130
Review Article
An overview of targeted alpha therapy with <sup>225</sup>Actinium and <sup>213</sup>Bismuth
, 2018; 11(3): 200-208.Alfred Morgenstern*, Christos Apostolidis, Clemens Kratochwil, Mike Sathekge, Leszek Krolicki and Frank Bruchertseifer
DOI: 10.2174/1874471011666180502104524
Review Article
PET/CT with <sup>68</sup>Ga-PSMA in prostate cancer: Radiopharmaceutical background and clinical implications
, 2018; 11(1): 4-13.Giampiero Giovacchini*, Elisabetta Giovannini, Mattia Riondato and Andrea Ciarmiello
DOI: 10.2174/1874471010666171101121803
Review Article
Development of <sup>225</sup>ac radiopharmaceuticals: TRIUMF perspectives and experiences
, 2018; 11(3): 156-172.Andrew Kyle Henderson Robertson, Caterina Fortunata Ramogida, Paul Schaffer and Valery Radchenko*
DOI: 10.2174/1874471011666180416161908
Review Article
The production of Ac-225
, 2018; 11(3): 173-179.Jonathan W. Engle*
DOI: 10.2174/1874471011666180418141357
Review Article
Review: The role of radiolabeled DOTA-conjugated peptides for imaging and treatment of childhood neuroblastoma
, 2018; 11(1): 14-21.Natasha Alexander, Reza Vali, Hojjat Ahmadzadehfar, Amer Shammas and Sylvain Baruchel*
DOI: 10.2174/1874471011666171215093112
Review Article
Radiopharmaceuticals labelled with copper radionuclides: Clinical results in human beings
, 2018; 11(1): 22-33.Giulia Anna Follacchio*, Maria Silvia De Feo, Giuseppe De Vincentis, Francesco Monteleone and Mauro Liberatore
DOI: 10.2174/1874471011666171211161851
Research Article
Biochemical and histopathological evaluation of the radioprotective effects of melatonin against gamma ray-induced skin damage
, 2019; 12(1): 72-81.Dheyauldeen Shabeeb, Masoud Najafi, Ahmed Eleojo Musa, Mansoor Keshavarz, Alireza Shirazi*, Gholamreza Hassanzadeh*, Mohammed Reza Hadian and Hedayat Samandari
DOI: 10.2174/1874471012666181120163250
Research Article
Evaluating the radioprotective effect of curcumin on rat’s heart tissues
, 2019; 12(1): 23-28.Sedighe Kolivand, Peyman Amini, Hana Saffar, Saeed Rezapoor, Elahe Motevaseli*, Masoud Najafi*, Farzad Nouruzi, Dheyauldeen Shabeeb and Ahmed Eleojo Musa
DOI: 10.2174/1874471011666180831101459
Review Article
Clinical studies with Bismuth-213 and Actinium-225 for hematologic malignancies
, 2018; 11(3): 192-199.Joseph G. Jurcic*
DOI: 10.2174/1874471011666180525102814
Review Article
Dosimetry and radiobiology of alpha-particle emitting radionuclides
, 2018; 11(3): 209-214.George Sgouros*, Robert Hobbs and Anders Josefsson
DOI: 10.2174/1874471011666180426130058
Research Article
In vivo evaluation of [ <sup>225</sup> Ac]Ac-DOTA <sup>ZOL</sup> for α-therapy of bone metastases
, 2018; 11(3): 223-230.Nina Pfannkuchen, Nicole Bausbacher, Stefanie Pektor, Matthias Miederer and Frank Rosch*
DOI: 10.2174/1874471011666180604083911
Research Article
Italian tailored assessment of lung indeterminate accidental nodule by proposing a segmental PET/computed tomography (S-PET/CT): Rationale and study design of a retrospective, multicenter trial
, 2018; 11(1): 46-49.Laura Evangelista, Marco Spadafora*, Leonardo Pace, Luigi Mansi and Alberto Cuocolo
DOI: 10.2174/1874471010666171002113700
Research Article
Preparation and dosimetry evaluation of a carrier-free<sup>90</sup>Y labeled DOTMP as a promising agent for bone marrow ablation
, 2018; 11(2): 116-122.Nafise Salek*, Sara Vosoghi, Simindokht S. Arani, Ali B. Samani, Mohsen Mehrabi and Mohammad G. Maraghe
DOI: 10.2174/1874471011666180412165722
Research Article
Automated synthesis of <sup>68</sup>Ga-DOTA-TOC with a cationic purification system: Evaluation of methodological and technical aspects in routine preparations
, 2018; 11(2): 130-137.Licia Uccelli*, Alessandra Boschi, Corrado Cittanti, Petra Martini, Luca Lodi, Elisa Zappaterra, Simona Romani, Samanta Zaccaria, Davide Cecconi, Ilaria Rambaldi, Ivan Santi, Stefano Panareo, Melchiore Giganti and Mirco Bartolomei
DOI: 10.2174/1874471011666180509101420
Most Accessed Articles
[68Ga]-Dota Peptide PET/CT in Neuroendocrine Tumors: Main Clinical Applications
, 2019; 12(1): 11-22.Elisabetta Giovannini, Giampiero Giovacchini, Elisa Borsò, Patrizia Lazzeri, Mattia Riondato, Rossella Leoncini, Valerio Duce and Andrea Ciarmiello*
DOI: 10.2174/1874471012666181212101244
Determination of Gamma Camera’s Calibration Factors for Quantitation of Diagnostic Radionuclides in Simultaneous Scattering and Attenuation Correction
, 2019; 12(1): 29-39.Afrouz Asgari, Mansour Ashoor, Leila Sarkhosh, Abdollah Khorshidi* and Parvaneh Shokrani
DOI: 10.2174/1874471011666180914095222
Utility of Molecular Imaging with 2-Deoxy-2-[Fluorine-18] Fluoro-D-Glucose Positron Emission Tomography (18F-FDG PET) for Small Cell Lung Cancer (SCLC): A Radiation Oncology Perspective
, 2019; 12(1): 4-10.Omer Sager*, Ferrat Dincoglan, Selcuk Demiral, Bora Uysal, Hakan Gamsiz, Yelda Elcim, Esin Gundem, Bahar Dirican and Murat Beyzadeoglu
DOI: 10.2174/1874471012666181120162434
An Overview of Targeted Alpha Therapy with 225Actinium and 213Bismuth
, 2018; 11(3): 200-208.Alfred Morgenstern*, Christos Apostolidis, Clemens Kratochwil, Mike Sathekge, Leszek Krolicki and Frank Bruchertseifer
DOI: 10.2174/1874471011666180502104524
Peptide Receptor Radionuclide Therapy for Pancreatic Neuroendocrine Tumours
, 2019; 12(2): 126-134.Shahad Alsadik, Siraj Yusuf and Adil AL-Nahhas*
DOI: 10.2174/1874471012666190201164132
[18F]Amylovis as a Potential PET Probe for β-Amyloid Plaque: Synthesis, In Silico, In vitro and In vivo Evaluations
, 2019; 12(1): 58-71.Suchitil Rivera-Marrero, Laura Fernández-Maza, Samila León-Chaviano, Marquiza Sablón-Carrazana, Alberto Bencomo-Martínez, Alejandro Perera-Pintado, Anais Prats-Capote, Florencia Zoppolo, Ingrid Kreimerman, Tania Pardo, Laura Reyes, Marcin Balcerzyk, Geyla Dubed-Bandomo, Daymara Mercerón-Martínez, Luis A. Espinosa-Rodríguez, Henry Engler, Eduardo Savio* and Chryslaine Rodríguez-Tanty*
DOI: 10.2174/1874471012666190102165053
Physiopathological Premises to Nuclear Medicine Imaging of Pancreatic Neuroendocrine Tumours
, 2019; 12(2): 98-106.Vincenzo Cuccurullo*, Giuseppe Danilo Di Stasio and Luigi Mansi
DOI: 10.2174/1874471012666190206094555
Gamma Emitters in Pancreatic Endocrine Tumors Imaging in the PET Era: Is there a Clinical Space for 99mTc-peptides?
, 2019; 12(2): 156-170.Vittorio Briganti*, Vincenzo Cuccurullo, Giuseppe Danilo Di Stasio and Luigi Mansi
DOI: 10.2174/1874471012666190301122524
Imaging of Pancreatic-Neuroendocrine Tumours: An Outline of Conventional Radiological Techniques
, 2019; 12(2): 135-155.Muhammad Affan Zamir, Wasim Hakim*, Siraj Yusuf and Robert Thomas
DOI: 10.2174/1874471012666190214165845
Dosimetry and Toxicity Studies of the Novel Sulfonamide Derivative of Sulforhodamine 101([18F]SRF101) at a Preclinical Level
, 2019; 12(1): 40-48.Ingrid Kreimerman, Erick Mora-Ramirez, Laura Reyes, Manuel Bardiès, Eduardo Savio* and Henry Engler
DOI: 10.2174/1874471011666180830145304
  |
Editor-in-Chief
Sean L. Kitson
Department of Biocatalysis and Isotope Chemistry Almac Sciences
Almac House
Craigavon
Northern Ireland
Biography
View Full Editorial Board
Department of Biocatalysis and Isotope Chemistry Almac Sciences
Almac House
Craigavon
Northern Ireland
Biography
Biography of Sean L. Kitson
Dr Kitson is an Investigator of Radiochemistry at Almac, UK. He has over 15 years of experience in the synthesis of carbon-14 labelled compounds. Dr Kitson is the Editor-in-Chief of Current Radiopharmaceuticals published by Bentham Science Publishers and the Journal of Diagnostic Imaging in Therapy. He has published over 45 research, reviews and commercial articles in the area of carbon-14 synthesis and medical imaging. His contribution to radiochemistry was acknowledged by winning the 2006 Wiley Journal of Labelled Compounds and Radiopharmaceuticals Young Scientists Award. Since, 2007 he has been a Member of the Scientific Committee for the International Isotopes Society (IIS) UK group.
About the Journal
For Authors
For Librarians & Readers
Journal History
Current Radiopharmaceuticals Journal was launched in 2008. Dr. Sean L. Kitson serves as the Editor-in-Chief of the journal.
Webmaster Contact: info@benthamscience.net